Nephrocare Health Services has reported consolidated revenue from operations of Rs 2.66 billion (Rs 266 crore) and consolidated net profit of Rs 303.7 million (Rs 30.37 crore) for the March 2026 quarter. Alongside strong quarterly results, the company has announced plans to invest up to Rs 100 million (Rs 10 crore) in Nephrocare Health Services Nepal, marking its international expansion into the neighboring South Asian market.
Strong Quarterly Financial Performance
Nephrocare Health Services Ltd delivered consolidated revenue of Rs 266 crore during the January-March 2026 quarter, reflecting robust growth in India's specialized healthcare services sector. The company posted consolidated net profit of Rs 30.37 crore, demonstrating healthy profitability in the dialysis and kidney care services segment. This performance underscores increasing demand for nephrology and renal care services driven by rising chronic kidney disease prevalence, expanding insurance coverage, and growing awareness about kidney health management across urban and semi-urban markets.
Strategic Investment in Nepal Operations
The company has announced investment plans of up to Rs 10 crore in Nephrocare Health Services Nepal, representing a strategic move to expand its geographical footprint beyond India. This international expansion into Nepal aligns with the company's growth strategy of establishing dialysis centers and kidney care facilities in underserved markets where access to quality nephrology services remains limited. The Nepal market offers significant potential given rising lifestyle diseases, inadequate dialysis infrastructure, and proximity to India's operational expertise.
Regional Expansion and Market Opportunity
Nepal's healthcare sector faces acute shortage of dialysis facilities relative to patient demand, creating attractive opportunities for specialized service providers like Nephrocare. The investment will likely support establishment of dialysis centers, procurement of equipment, hiring medical professionals, and building operational infrastructure. Success in Nepal could serve as a template for further expansion into other South Asian and emerging markets with similar healthcare gaps.
Key Highlights
- Nephrocare Health Services reports Q4 FY26 consolidated revenue of Rs 2.66 billion (Rs 266 crore)
- Consolidated net profit for March quarter stands at Rs 303.7 million (Rs 30.37 crore)
- Company announces investment of up to Rs 100 million (Rs 10 crore) in Nepal subsidiary
- Nepal expansion marks strategic international foray into underserved dialysis services market
- Strong quarterly results reflect growing demand for specialized kidney care and dialysis services
- Rising chronic kidney disease prevalence driving market growth across India and South Asia
- Nepal investment to support establishment of dialysis centers and healthcare infrastructure
Sources: BSE/NSE exchange filings and Nephrocare Health Services Ltd quarterly results and corporate announcements